In this commentary, I review recent advances in Alport syndrome genetics, diagnostics, and therapeutics. I also offer some opinions regarding strategies to optimize the early identification of affected individuals to promote early therapeutic intervention.
Bibliographical notePublisher Copyright:
© 2017 Kashtan C.
- Alport syndrome
- Collagen IV alpha-345 network
- End-stage renal disease